Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial
Figure 2
Proportion of patients who reported symptom relief for each individual symptom from baseline. The number of patients listed for each symptom is the number of patients that reported that symptom with a GOS score ≥4 at baseline.* between the two treatment groups at week 4.
